Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and destructiveHint=false. The description adds substantial behavioral context: it cascades through multiple lookup endpoints, degrades gracefully if GLEIF/OpenFIGI are unavailable, explicitly lists unresolved identifiers under `unresolved`, and returns `figi_candidates` rather than asserting when ambiguous. It also clarifies that non-equity instruments resolve even without tickers. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Although long, the description is tightly organized: it starts with usage examples, then the core purpose, then detailed per-type behavior, and finally notes about degradation and efficiency. Every sentence carries necessary information for correct invocation, and the structure front-loads the most critical guidance. The length is justified by the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description fully explains return behavior: identifiers, source labeling, `unresolved` field, `figi_candidates` for ambiguity, and graceful degradation. It covers edge cases (non-US issuers, bonds, ambiguous names) and input constraints. An agent can correctly call this tool without additional documentation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The schema provides only basic descriptions for `type` and `value`. The description enriches both: for `value`, it lists accepted formats (ticker, CIK, ISIN, name) for company, and brand/generic for drug, with a concrete example and a warning against including trailing security-class words. It also explains the behavior for ambiguous names, adding meaning far beyond the schema fields.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user-phrase examples and then states the core purpose: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It specifies the verb 'resolve,' the resource (entities with types), and explicitly differentiates from siblings by saying 'Use FIRST whenever you have a name but need an ID.' This leaves no ambiguity about what the tool does.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also details when to use each type (company vs drug) and provides input format rules, including a critical caution about bond issuer names. It notes the tool replaces 2-3 manual lookups and explains how ambiguous matches are handled, so an agent knows exactly when to call it versus alternatives.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Several tools blur together: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all answer factual questions with overlapping routing behavior, while polymarket_edges, polymarket_arbitrage, and bet_research all surface prediction-market opportunities. Long descriptions help, but the boundaries between these clusters are genuinely unclear, and the three IEEE tools are buried in a sea of unrelated Pipeworx tools.

Naming Consistency4/5

The naming is predominantly snake_case with clear family prefixes like ieee_, ask_pipeworx_, and polymarket_, and most tools follow a readable verb_noun or noun_verb shape. Minor deviations exist (remember/recall/forget, bet_research, pipeworx_trending) but there is no camelCase/mixed-convention problem, so the overall pattern is predictable.

Tool Count1/5

A server named 'Ieee Standards' exposes 34 tools, yet only three of them (ieee_search, ieee_standard_search, ieee_article) actually serve that domain. The remaining 31 tools form a general Pipeworx data, prediction-market, memory, and subscription platform, which is an extreme scope mismatch for the stated server purpose.

Completeness4/5

For the IEEE lookup domain, the three IEEE tools cover the core read-only workflow: broad corpus search, standards-specific search, and full metadata retrieval by article number or DOI. Minor gaps exist (browsing by committee, revision/status history, full-text access) but those are workable or inherently restricted by IEEE's paywall.